Pembrolizumab for locally advanced cervical cancer - Authors' reply.
Saved in:
| Title: | Pembrolizumab for locally advanced cervical cancer - Authors' reply. |
|---|---|
| Authors: | Lorusso D; Gynaecological Oncology Medical Unit, Humanitas Hospital San Pio X, Milan 20159, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. Electronic address: domenica.lorusso@hunimed.eu., Yamada K; Merck, Rahway, NJ, USA., Li K; Merck, Rahway, NJ, USA., Cerrotta A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Macchia G; Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. |
| Source: | Lancet (London, England) [Lancet] 2024 Nov 23; Vol. 404 (10467), pp. 2051-2052. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-547X |
|---|---|
| DOI: | 10.1016/S0140-6736(24)02232-3 |
